Filters
Categories
Dates
Tags
Event Types
Filters
The 23rd Annual Meeting of the Japanese Socie...
We are pleased to announce that the 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will be held over three days from Thursday, March 26, to Saturday, March 28, 2026, at PACIFICO Yokohama North and Exhibition Hall D (Yokohama, Japan). The theme of this meeting is “Medical Oncologists for Cancer Patients”.
Since 2006, JSMO has been conducting board certification in medical oncology. In 2026, the program will mark its 20th anniversary, having training around 2,000 medical oncologists in Japan. This significant occasion provides an opportunity to explore the ideal role of the “Medical Oncologist”. We will examine their contributions to cancer treatment and research, their role in standardizing cancer care, and their involvement in team-based approaches. Additionally, we aim to consider cancer patients’ perspectives, the required number of specialists, regional and institutional disparities, and issues related to domestic and international board certification systems. Through these discussions, we hope to clarify the future direction of board certification in medical oncology.
JSMO2026 will also focus on "Asian Oncology," highlighting contributions from Asia regarding clinical oncology for cancer treatment. We aim to revisit the history of outstanding basic research and novel evidence on anti-cancer drug development originating from Asian countries, including Japan, across various cancer fields. Furthermore, we will explore the future of collaborative research in Asia, and address opportunities for oncologic education as well as the relationships among young oncologists in the region.
In addition, JSMO2026 will showcase the latest high-level evidence in oncology, fostering in-depth discussions during the meeting. We look forward to receiving numerous general abstract submissions on these subjects from both domestic and international participants. Through active discussions on the latest evidence, we aim to further promote international collaboration and advancements in the field.
The meeting will also cover various topics, such as anti-cancer drug development, cancer genome medicine, personalized medicine, perioperative chemotherapy, and cancer care tailored to different life stages (including pediatrics, the AYA generation, and elderly cancer patients). Additional topics include onco-fertility, hereditary tumors, and the intersection of cancer care with patients, their families, and society.
Late March in Japan is typically a season of pleasant weather, with cherry blossoms in full bloom. We hope that many colleagues from both Japan and overseas will join us, enriching academic discussions and enjoying the scenic views and culinary delights of the port city of Yokohama
Advancing the Science of Cancer in Latinos 20...
The Mays Cancer Center and the Institute for Health Promotion Research at UT Health San Antonio hosts the international conference, Advancing the Science of Cancer in Latinos biennially in San Antonio, Texas This conference comes at an especially important time when Latinos – the largest, youngest, and fastest-growing minority group in the U.S. – are expected to face a 142% rise in cancer cases in coming years. Disparities continue to plague this population in access to care, risk factor behaviors, mortality, and quality of life. Our vision has been to unite researchers, scientists, physicians, healthcare professionals, patient advocates and students from across the nation and beyond, in an open dialogue, under one roof, to discuss research advancements to date, identify gaps, and develop actionable goals to translate basic research into clinical best practices, effective community interventions, and professional training programs to eliminate cancer disparities in Latinos.
The Advancing the Science of Cancer in Latinos conference brings together leading experts in the field of cancer health disparities, cancer science and community. These respective leaders in the field will discuss research advancements to date, gaps in Latino healthcare, actionable goals to translate basic research into clinical best practices, social determinants of health, effective community interventions, and professional training programs to eliminate cancer disparities in Latinos.
We hope you will join us in 2026 to gain a comprehensive perspective on Latino cancer health disparities, learn how you can apply some of this research and practice into your own work, and help us foster more collaboration, more research, and more success in improving the health and lives of Latinos.
ASCO Gastrointestinal Cancers Symposium
ASCO Promotes and Provides For Lifelong learning for oncology professionals, Cancer research, An improved environment for oncology practice, Access to quality cancer care, A global network of oncology expertise, and Educated and informed patients with cancer.
7th Federation of Asian Organizations for Rad...
Greetings from Chiang Mai, a city in Northern Thailand that seamlessly weaves modernity with tradition.
We are delighted that Thai Association of Radiation Oncology (THASTRO) will be hosting the 7th Federation of Asian Organizations for Radiation Oncology (FARO) meeting jointly with the 36th THASTRO annual meeting from 13th to 15th November 2025 at The Empress Convention Center, Chiang Mai, Thailand.
The theme of the conference is “Unveiling the Power of Comprehensive Cancer Care” as we aim to focus on the delivery of multidisciplinary treatment throughout the cancer care journey, which will empower us to provide the best care for our patients. Our program comprises of various sessions, including pre-congress hands-on workshop, special lectures by renowned speakers, and the latest research developments through proffered oral and poster presentations.
We are excited to bring together radiation oncologists, medical physicists, radiotherapy technicians, nurses, clinicians, and those who are interested in any aspect of radiation oncology to join us.
Join us at FARO 2025 x 36th THASTRO for an exceptional experience.
ISO-ISMPOCON 2025
We are pleased to invite you to participate in the "ISO-ISMPOCON 2025" conference, which will be held from 31st October, 01st & 2nd November 2025 at Mahatma Gandhi Medical College & Hospital, Jaipur. The joint collaborative conference of the Indian Society of Oncology (ISO) and Indian Society of Medical & Pediatric Oncology (ISMPO) societies is organized every two years and we are grateful to the Executive Committees of the two major oncology bodies in India to have alloted the 2025 conference to Jaipur and to the Mahatma Gandhi University of Medical Sciences & Technology. We propose to hold the conference on our campus.
This time the theme of the conference is "Winning the Battle Against Cancer- From Insights to Impact!"
The program will bring together pioneering minds from research, clinical practice and stalwarts of the medical field to push forward the boundaries of cancer care. Our goal is not only to deepen insights but to drive impactful changes in patient outcomes.
This conference will be a catalyst for collaboration and inspiration, empowering each participant to contribute to the global fight against cancer with renewed knowledge, tools, and hope.
Set against the vibrant backdrop of Jaipur, also known as the Pink City, this conference offers a unique blend of scientific rigor and cultural richness. With its majestic palaces, intricate architecture, busy markets and trademark culinary delicacies, Jaipur provides an inspiring atmosphere to learn, connect, and unwind. The city offers delegates' a memorable experience, combining groundbreaking discussions with the allure of Rajasthan's rich history and colorful traditions.
We welcome you all to be a part of this Conference with like minded people.
'Padaro Maharee Desh' - Welcome to my part of the world!
NE AROICON 2025
19th Annual Conference of Association of Radiation Oncologists of India, North East Zonal Chapter
Organised by Department of Radiation Oncology, State Cancer Institute, Gauhati Medical College
15th Annual Conference of Indian Brachytherap...
Welcome to the 15th Annual Conference of Indian Brachytherapy Society Join us for the most comprehensive conference on advanced cancer treatments and Brachytherapy techniques. Connect with leading experts and discover the latest innovations in the field.
Latest research and developments Networking opportunities Oral presentations Poster presentation session Interactive sessions and video presentations Expert speakers
10th World Congress of IAOO
The International Academy of Oral Oncology (IAOO) is a multi-disciplinary community of clinicians and scientists working on issues relating to the etiopathogenesis, epidemiology, prevention and management or oral and perioral tumours of oral disease in patients with malignancies. IAOO exists to bring together clinicians and scientists working in the fiels of oral oncology, so that advances in medical science can be made and translated speedily into benefits for patients.
The World Congress of the Academy is an opportunity for the IAOO community to meet and exchange ideas and innovation in the field of oral oncology. The Congress is the only global gathering of Head and Neck Surgeons, Radiation and Medical Oncologists, Maxillo-Facial Surgeons, Otorhinolaryngologists and all other allied specialists in oral cancer care.
A world-class Scientific Programme and accompanying Social Programme, inclusive and accessible to all, is being planned by the Local Organising Committee for IAOO 2025 in Liverpool, UK.
"From in-person in Liverpool, online and available across the World, sharing the best scientific and educational content available to all healthcare professionals involved in the management of oral malignency".
We look forward to welcoming you to Liverpool in 2025.
World Congress on Thyroid Cancer (WCTC) 2025
After a superb virtual program on June 29, 2024, we are now focused on our next in-person congress to be held July 9-12, 2025 in Boston.
We anticipate an exceptional meeting and encourage you to make plans now to attend.
WCTC is highly regarded as the most comprehensive and cutting-edge scientific program available for thyroid professionals. Led by a team of international experts, attendees are immersed in a multi-disciplinary agenda featuring keynotes, meet the professor, lively debates and panel discussions, hands-on demonstrations and much more.
ESTRO 2025
It is my great pleasure to invite you back to Vienna, Austria for The European Society for Radiation Therapy and Oncology (ESTRO) 2025 which will take place from 2 to 6 May. Building on the huge success of previous congresses in this vibrant city, situated ideally in the centre of Europe, we will convene the radiation oncology community for five days of learning, collaborating and connecting.
The ambition of ESTRO to further reinforce radiation oncology as a key partner in multidisciplinary cancer care, and to guarantee accessible and high-value radiation therapy for all cancer patients who need it, is expressed in the society’s vision statement for 2030: ‘Radiation Oncology. Optimal Health for All, Together.’
Continuous evolution and refinement of radiation oncology is one important path of innovation to achieve this goal. ESTRO 2025 will put an emphasis on breakthrough research and innovation. Such revolutionary innovation is happening within our discipline, and even more opportunities open by collaboration and partnership with neighbouring and even distant fields of research. With this aim, the congress theme is Transformative Innovation Through Partnership. The programme will focus on how all stakeholders can learn from each other and cooperate to push the boundaries of radiation oncology and multidisciplinary cancer care in general. The theme will be reflected throughout the programme via state-of-the-art sessions.
The programme will emphasise interaction between audience and faculty, making top-level science accessible for all attending. Featuring panel discussions, pitch sessions and debates, the programme will connect the whole radiotherapy community. Leaders in the field will share their work and knowledge via symposia and teaching lectures. Joint sessions with partner associations will connect delegates with new communities and increase the reach of the ESTRO population. Nurturing those starting out in their careers remains a pillar of the society and therefore the Young Track will continue to provide educational activities focussed on those in the earlier stages of their careers. All sessions will promote collaboration between faculty and audience.
ESTRO strives to showcase the top-level scientific work being carried out by the radiation oncology community. With this in mind, the best abstract submitted to each track will be celebrated in a best proffered paper session. Other sessions will showcase the latest trial results. In addition to these highlight sessions, ESTRO will recognise the top-tier abstracts submitted to the congress. The highly popular mini-oral sessions will continue, enhancing the visibility of submitted research, while poster discussion sessions offer a platform to showcase work. We will continue to emphasise the interdisciplinarity of the ESTRO scientific programme by calling for abstracts which are of interest to a broad range of disciplines.
The main purpose of the ESTRO annual congress is to disseminate the latest science within the world of radiotherapy but also to reach out to the larger medical community and society in general. We will be increasing our communication of the breakthrough science via social channels and the press both during and after the congress. This will ensure engagement for those presenting at ESTRO 2025 far beyond the congress itself.
Networking with corporate partners is always invaluable. ESTRO 2025 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and to find out about the latest innovations in the field.
We look forward to welcoming you in Vienna.
19th Head and Neck Cancer Symposium (Hybrid)
Oral cancer remains the most common disfiguring and deadly disease that oral health care providers, including general dentists, specialists, physicians, and staff encounter in practice.
This course provides clinicians with the knowledge to understand the various etiologic factors of oral cancer and enhances their ability to recognize early potentially malignant and malignant changes within the oral cavity. Course attendees will learn to effectively communicate with their patients and colleagues regarding appropriate management. This course also discusses the complex nature of such treatment and the complications that may ensue, as well as their potential to affect dental treatment.
Learning Objectives Name conventional and newly-recognized factors for head and neck cancer, including cutaneous and non-squamous malignancies List the oral complications of oral cancer therapy and their implications for oral health care providers Outline a management strategy for patients with advanced stage oral cancer Define the complications associated with the surgical and medical management of head and neck cancer
Mayo Clinic Multidisciplinary Head and Neck C...
This course offers Live (in-person) and Livestream (virtual) attendance options.
Mayo Clinic’s Multidisciplinary Head and Neck Cancer Symposium is dedicated to the latest advancements in head and neck cancer care, encompassing surgical oncology, radiation oncology, medical oncology, and symptom control/survivorship. This three-day symposium features a blend of multidisciplinary sessions and specialized tracks, including hands-on learning and small breakout sessions. It begins with a multidisciplinary session on day one, continues with subspecialty breakouts on day two, and concludes with another multidisciplinary session on day three.
Target Audience This course is intended for otolaryngologists, head and neck surgeons, medical and radiation oncologists, laboratory scientists, physician assistants, nurse practitioners, registered nurses, oncology pharmacists, oncology nurses, speech and language pathologists, physical therapists, dietitians, dentists, clinical research personnel, and other allied health staff involved in the care of head and neck cancer patients. Specialties include medical oncology, radiation oncology, surgical oncology/ENT, pathology, radiology, and laboratory research science.
Learning Objectives Upon completion of this activity, participants should be able to:
Examine the latest advancements in mucosal Head and Neck cancer care. Describe best practices for symptom control in Head and Neck Cancer survivorship. Develop effective community engagement strategies to enhance HPV vaccination uptake. Discuss novel treatment options for Head and Neck cancer patients. Discuss multidisciplinary management of acute toxicity for Head and Neck cancer patients. Evaluate the role of biomarkers in treatment planning for Head and Neck cancer patients.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Join the Academic Alerts
Connect with scholars worldwide, share knowledge, and stay updated with the latest academic events and buzz.